|
Light Cigarettes as Deadly as Regulars
Excerpt
By
Todd Zwillich, Reuters Health
WASHINGTON (Reuters Health)
- ``Light'' and ``low-tar'' cigarettes have done nothing to reduce
the rates of smoking-related deaths since their introduction in
the 1970s, and may have even contributed to a rise in illness
rates among smokers, according to a US government report released
Tuesday.
Anti-smoking groups said that the marketing of low-tar and light
cigarettes has deceived the public and policymakers into thinking
that it is possible to smoke without a high risk of lung cancer
and other diseases. Many public health authorities advocated the
use of low-tar cigarettes throughout the 1980s as a means to reduce
the health risk associated with tobacco.
``There's no safe cigarette. The only way to reduce your risk
from smoking is not to start, or to quit,'' said Dr. David M.
Burns, the senior scientific editor of the report, published by
the National Cancer Institute.
``Smokers are being duped. They're being conned. It's a scam
that's being put forward on the American public by the tobacco
industry,'' said John L. Kirkwood, CEO of the American Lung Association.
A statement issued by Phillip Morris USA, the maker of several
popular cigarette brands including Marlboro Lights, said that
tar levels in government tests are averages that show relative
differences in toxin yields between brands, not risk differences
to smokers.
``The tar and nicotine yield numbers that are reported for cigarette
brands are not meant (and were never intended) to communicate
the precise amount of tar or nicotine inhaled by any individual
smoker from any particular cigarette,'' the statement read.
``Tar'' is a catch-all phrase used to describe levels of dozens
of toxic chemicals in cigarettes. The Federal Trade Commission
allows tobacco companies to tout ``low-tar'' and light cigarettes
if tar and nicotine levels fall below a certain point in machine
tests.
Burns and others said that public health experts assumed starting
in the 1960s that reducing tar levels would help smokers who did
not quit to reduce their health risk. The assumption did not take
into account a key fact that government sampling machines miss:
smokers take deeper puffs or simply smoke more cigarettes to compensate
for the lower nicotine in each cigarette.
Results in the report show that people who smoked ``light,''
''ultra light'' or low-tar cigarettes had the same overall tar
exposure as those smoking regular cigarettes. They also show that
the death rates from smoking-related illnesses such as lung cancer
and heart disease were similar in the different groups.
Some data, though still preliminary, even suggest that the widespread
use of light cigarettes may have contributed to a rise in smoking-related
illness. Overall death rates from lung cancer among women rose
from 44 per 100,000 in the mid-1960s to 119 per 100,000 in the
mid-1980s, according to the report. Similar trends were seen for
men, and the rises correspond to a flood of light and low-tar
cigarettes on the market.
One possible culprit is that smokers may inhale smoke from light
cigarettes deeper into the lungs to increase their nicotine dose.
The deeper inhalations could increase the risk of certain deep
lung cancers like adenocarcinoma, said Burns, a professor of medicine
at the University of California, San Diego.
``We can't say that for certain, but things didn't get any better''
with the advent of light cigarettes, he said.
Activists attacked tobacco companies who promote new reduced-carcinogen
cigarettes as a healthier way to smoke. One new product called
Omni, sold by Liggett & Myers subsidiary Vector Tobacco, uses
a chemical treatment to keep some toxic gasses out of smoke. Another
product, RJ Reynolds' ``Eclipse,'' promotes the reduced-toxin
cigarette as the safest alternative for people who choose to smoke.
``We have no more proof...that the products and claims being
introduced today will produce any more of a reduction in disease
risk than the products introduced by the tobacco industry 40 years
ago,'' said Matthew L. Meyers, president of the Campaign for Tobacco-Free
Kids.
Meyer and leaders from the American Cancer Society the US Food
and Drug Administration (FDA) the authority to regulate tobacco
products. The Supreme Court barred the FDA from regulating tobacco
in 1996 because the agency lacked the appropriate legal authority.
``Without FDA authority, the tobacco industry will continue to
be free to use advertising and marketing gimmicks to portray their
deadly product as safer and less harmful,'' said M. Cass Wheeler,
CEO of the American Heart Association.
In a statement, Phillip Morris said that the company sees ''FDA
regulation as the best way to establish appropriate standards
for determining what is a 'reduced risk' cigarette. This would
include setting guidelines for any claims that could be made by
manufacturers, including the type and manner of communication
that should be provided to consumers.''
Reference
Source 89
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|